Cytotec Tablets: The Dual Nature of Misoprostol and Why Context Changes Everything

 Cytotec is a medicine that means different things depending on who is holding the packet. To a patient with arthritis taking long-term NSAIDs, it is a stomach protectant. To a woman accessing abortion care, it is the active drug that ends a pregnancy. To a maternity unit, it is a tool for inducing labour. The same 100 mcg tablet of misoprostol sits at the centre of all three.

That dual nature is not a quirk of marketing. It is written into the drug's regulatory status, its safety warnings, and the legal frameworks of Denmark and the UK. Understanding Cytotec means understanding that the indication—not just the molecule—determines whether it is helpful or hazardous.

The Approved Indication: Protecting the Stomach from NSAIDs

Cytotec 100 mcg contains misoprostol, a synthetic prostaglandin E1 analogue. Its licensed use in the UK and many other markets is prevention of gastric and duodenal ulcers in patients taking non-steroidal anti-inflammatory drugs . NSAIDs reduce prostaglandin production in the stomach lining, which can lead to ulcers. Misoprostol replaces some of that prostaglandin activity, increasing bicarbonate and mucus production to protect the mucosa .

The dosing for this indication is typically 200 mcg four times daily with food. Cytotec tablets are manufactured in 100 mcg strengths, so two tablets per dose. The Japanese product information for Cytotec describes exactly this regimen: two 100 mcg tablets four times daily, after meals and at bedtime .

This is the ordinary, unremarkable use of the drug. Patients taking it for stomach protection are usually older adults with arthritis or chronic pain who need NSAIDs but cannot tolerate them without mucosal cover.

The Unapproved Use That Defines the Drug's Reputation

Misoprostol's abortifacient property is not a side effect in the casual sense. It is a direct consequence of what prostaglandins do to the uterus. They cause contractions. In early pregnancy, those contractions can expel the pregnancy.

The FDA's label for Cytotec carries a boxed warning stating plainly that the drug can cause abortion, sometimes incomplete, which can lead to dangerous bleeding requiring hospitalisation and surgery. It also warns of premature birth and birth defects if used during pregnancy, and instructs patients to avoid pregnancy while taking it and for at least one month after stopping .

The UK BNF is equally direct. Misoprostol is contraindicated in women planning pregnancy and should be avoided in pregnancy because it is a potent uterine stimulant with teratogenic risk in the first trimester .

Off-label, misoprostol is used for medication abortion, often in combination with mifepristone. A 2024 review in NEJM Evidence examined misoprostol-only regimens and noted that the National Abortion Federation and Society of Family Planning updated their recommended protocol in 2023 to 800 mcg administered buccally, sublingually, or vaginally every three hours for three or more doses . In Denmark, historical guidance from the National Board of Health describes vaginal application of 800 mcg misoprostol as part of medical abortion protocols used in public hospitals .

The critical point for patients in Denmark and the UK is that this use is not the licensed indication for Cytotec. It occurs within regulated healthcare settings, under clinical supervision, with protocols that differ from the stomach-protection dosing.

Safety Warnings That Apply Regardless of Indication

Some risks follow misoprostol wherever it is used. Uterine rupture is the most serious. The FDA warns that rupture has been reported when misoprostol is given after the eighth week of pregnancy, and that the risk increases with advancing gestational age and prior uterine surgery, including caesarean delivery. Rupture can cause severe bleeding, hysterectomy, and maternal or fetal death .

These warnings are most relevant to obstetric use, but they matter to anyone who might be pregnant while taking Cytotec for stomach protection. The contraindication is absolute: do not take misoprostol to reduce NSAID ulcer risk if you are pregnant.

The UK's MHRA has also issued safety advice about a misoprostol vaginal delivery system called Mysodelle, used for labour induction. A routine EU review found that 13% of women given the 200 mcg vaginal insert developed uterine tachysystole requiring intervention, and in five cases the excessive contractions did not respond to tocolytic treatment . This is a different formulation from oral Cytotec tablets, but it illustrates the potency of misoprostol on uterine tissue.

Practical Reality for Adults in Denmark and the UK

Cytotec is prescription-only in both countries. In the UK, it is not a pharmacy medicine and is not available over the counter. The 100 mcg tablets are manufactured by Pfizer and carry the familiar "Searle 1451" imprint .

For patients prescribed Cytotec for stomach protection, the practical advice is straightforward: take it exactly as directed, do not share it, and use effective contraception if you are a woman of childbearing potential. If pregnancy occurs while taking it, stop and contact a doctor immediately.

For anyone encountering Cytotec online or through informal channels, the risks are different and more immediate. Misoprostol obtained without a prescription and used without clinical supervision carries the full weight of the warnings above—haemorrhage, incomplete abortion, uterine rupture—without the safety net of a clinician who can manage complications.

The drug itself is neither good nor bad. It is a potent prostaglandin with a legitimate place in gastroenterology and a well-established role in reproductive healthcare when used within regulated protocols. The difference between those two realities is not the tablet. It is the context in which it is taken.